Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Allurion Technologies, Inc. Common Stock (NY:ALUR)

0.7084 +0.0284 (+4.18%)
Streaming Delayed Price Updated: 10:50 AM EST, Mar 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Allurion Technologies, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Monday's session: top gainers and losers ↗
Via Chartmill
News headline image
Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE
From Allurion Technologies, Inc.
Via Business Wire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
News headline image
Earnings Scheduled For November 12, 2025 ↗
 
Via Benzinga
News headline image
Preview: Allurion Technologies's Earnings ↗
 
Via Benzinga
Tuesday's session: top gainers and losers ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Why Did Allurion Stock Surge Over 50% Today? ↗
The U.S. Food and Drug Administration has granted premarket approval for Allurion’s Gastric Balloon System with the swallowable Allurion Smart Capsule. 
Via Stocktwits
News headline image
Allurion Receives U.S. FDA Approval
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion Announces Partnership to Offer Combination Therapy with Mounjaro® (tirzepatide) at Discounted Prices
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence
From Allurion Technologies, Inc.
Via Business Wire
News headline image
New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update
From Allurion Technologies, Inc.
Via Business Wire
News headline image
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
A Look at Allurion Technologies's Upcoming Earnings Report ↗
 
Via Benzinga
News headline image
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being Debt-Free, and Announces a $5 Million Private Placement Financing
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion to Report Third Quarter 2025 Financial Results on November 12, 2025
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion Announces Landmark Peer-Reviewed Publication on Consecutive Use of the Allurion Smart Capsule Showing More Than 20% Weight Loss
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
From Allurion Technologies, Inc.
Via Business Wire
News headline image
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Allurion Revenue Drops 71 Percent in Q2 ↗
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
Allurion Reports Second Quarter 2025 Financial Results and Provides Business Update
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion to Report Second Quarter 2025 Financial Results on August 13, 2025
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Earnings Scheduled For August 13, 2025 ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.